comparemela.com

Latest Breaking News On - Helenm thackray - Page 1 : comparemela.com

BioCryst Pharmaceuticals, Inc (NASDAQ:BCRX) Shares Purchased by Trexquant Investment LP

Trexquant Investment LP increased its position in shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Get Rating) by 44.8% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 106,470 shares of the biotechnology company’s stock after acquiring an additional 32,958 shares […]

BioCryst Pharmaceuticals (NASDAQ:BCRX) Sees Strong Trading Volume

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

BioCryst Pharmaceuticals, Inc (NASDAQ:BCRX) Expected to Announce Quarterly Sales of $63 92 Million

Equities research analysts predict that BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Get Rating) will post $63.92 million in sales for the current quarter, according to Zacks. Five analysts have made estimates for BioCryst Pharmaceuticals’ earnings, with estimates ranging from $59.15 million to $66.95 million. BioCryst Pharmaceuticals posted sales of $49.96 million during the same quarter last […]

Brokerages Expect BioCryst Pharmaceuticals, Inc (NASDAQ:BCRX) Will Post Earnings of -$0 36 Per Share

Equities research analysts expect BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Get Rating) to post ($0.36) earnings per share for the current quarter, Zacks reports. Five analysts have made estimates for BioCryst Pharmaceuticals’ earnings, with estimates ranging from ($0.48) to ($0.20). BioCryst Pharmaceuticals posted earnings per share of ($0.24) in the same quarter last year, which would […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.